SARS-CoV-2 SPIKE GLYCOPROTEIN-BINDING NUCLEIC ACID MOLECULE, SARS-CoV-2 DETECTION SENSOR, SARS-CoV-2 DETECTION REAGENT, SARS-CoV-2 DETECTION METHOD, AND SARS-CoV-2 VIRUS DEACTIVATOR

An example object of the invention is to provide a binding nucleic acid molecule capable of specifically binding to a SARS-CoV-2 spike glycoprotein. A SARS-CoV-2 spike glycoprotein-binding nucleic acid molecule according to an example aspect of the invention includes: any of the following polynucleo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Kato, Shintaro, Inaguma, Asumi, Minagawa, Hirotaka, Horii, Katsunori, Fujita, Tomoko
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PHYSICS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	An example object of the invention is to provide a binding nucleic acid molecule capable of specifically binding to a SARS-CoV-2 spike glycoprotein. A SARS-CoV-2 spike glycoprotein-binding nucleic acid molecule according to an example aspect of the invention includes: any of the following polynucleotides (a), and (b):(a) a polynucleotide consisting of any of base sequences of SEQ ID NOs: 1 to 7 or a partial sequence of any of the base sequences of SEQ ID NOs: 1 to 7;(b) a polynucleotide consisting of a base sequence having 80% or more identity to any base sequence of the polynucleotide (a), and binding to a SARS-CoV-2 spike glycoprotein: